GAGA Share Market News

[hfe_template id='11223'] [ad_1] India’s fear gauge, the Volatility Index (India VIX), surged over 6% to 21.68 on Wednesday, signalling rising investor anxiety amid a sharp selloff in global equities and renewed trade tensions. The spike in volatility comes as U.S. President Donald Trump vowed to impose “major tariffs” on pharmaceutical imports, sending Indian pharma stocks tumbling up to 6%. Meanwhile, metal stocks dropped as much as 4% after the U.S. raised import duties on Chinese goods by 50%, taking the total tariff burden to 104%. The move has raised concerns of China diverting its steel exports to other markets like India, intensifying competition for domestic producers. The growing fears of stagflation and a possible recession in the U.S. also weighed on sentiment, dragging down IT stocks and adding to market jitters. In early trade, the BSE Sensex declined 403 points, or 0.54%, to 73,823, while the Nifty50 dropped 146 points, or 0.65%, to 22,389 around 9:30 am. ...

[hfe_template id='11223'] [ad_1] Shares of Indian pharmaceutical companies, including Aurobindo Pharma, Laurus Labs, IPCA Laboratories, and Lupin, dropped as much as 7% on Friday after U.S. President Donald Trump signaled that tariffs on the sector were imminent. Speaking to reporters aboard Air Force One, Trump stated that his administration was evaluating potential tariffs on pharmaceuticals. “Pharma is going to start coming in at, I think, a level that you haven’t really seen before,” he said, hinting at forthcoming trade measures. He further clarified that pharmaceuticals were being considered as a separate category for tariffs, with an announcement expected soon. “We are looking at pharma as a separate category. We will be announcing that sometime in the near future—not in the distant future,” he added. The remarks come just a day after pharma stocks had rallied on expectations that the sector would be spared from trade restrictions. On Thursday, the Nifty Pharma in...